BusinessWeek Logo
November 22, 2009 4:14 AM ET
Pharmaceuticals and Biotechnology
Wyeth

Company Overview

Wyeth operates as a research-based pharmaceutical and healthcare company in the United States, the United Kingdom, and internationally. Its Pharmaceuticals segment develops, manufactures, distributes, and sells various products, including neuroscience therapies, vaccines, musculoskeletal therapies, nutritional products, gastroenterology drugs, anti-infectives, oncology therapies, hemophilia treatments, immunological products, and women’s healthcare products. This segment offers its products to wholesalers, pharmacies, hospitals, governments, physicians, retailers, and other human healthcare institutions. The company’s Consumer Healthcare segment develops, manufactures, distributes, and sells...

Detailed Description

Five Giralda Farms

Madison, NJ 07940

United States

Founded in 1926

47,426 Employees

Phone:

973-660-5000

Fax:

973-660-5771

www.wyeth.com

Key Executives

Chairman
Age: 57
Chief Financial Officer
Age: 51
Senior Vice President
Age: 55
Senior Vice President
Age: 50
President of US & New Global Business - Wyeth Consumer Healthcare
Age: 49
Compensation as of Fiscal Year 2009.

Key developments for Wyeth

U.S. Court of Appeals for the Eighth Circuit Upholds Jury Verdict on a Case Against Wyeth

The U.S. Court of Appeals for the Eighth Circuit upheld a jury verdict in Donna Scroggin v. Wyeth, et al. awarding Scroggin $2.7 million in compensatory damages for the breast cancer she developed after taking Prempro. However, the appeals court vacated the more than $27 million in punitive damages the jury levied against Wyeth and Pharmacia & Upjohn, a separate Pfizer unit that makes Provera (medroxyprogesterone acetate), one of the components of Prempro. The court remanded the case to the U.S. District Court for the Eastern District of Arkansas for a new trial to determine the punitive damages.

Buyers Reportedly Circling Inova Pharmaceuticals

Australian Financial Review reported that Sanofi-Aventis and Merck KGaA may be among bidders in the AUD 900 million sale of iNova Pharmaceuticals (Australia) Pty Limited. The report added that Archer Capital Pty. Ltd. and Ironbridge Capital Pty Ltd have short-listed bidders for iNova. It noted that GlaxoSmithKline Plc and Wyeth are also logical bidders for the business. It was reported that second-round offers are expected in December.

Philadelphia Jury Weighs Damages Against Wyeth

A Philadelphia jury is weighing punitive damages against Wyeth after finding a link between an Illinois woman's breast cancer and the hormone-replacement drug she took. Connie Barton's case is one of a handful of Prempro lawsuits to go to trial out of several thousand filed across the country. About 1,500 are pending in Philadelphia. The Philadelphia jury awarded $3.75 million in compensatory damages. They say the company's actions were willful and warrant punitive damages.

Similar Private Companies By Industry

Company Name Region
Oceana Therapeutics, Inc. United States
Abatic Pharmaceutical United States
TriLogic Pharma LLC United States
Royal Products Inc. United States
Selexys Pharmaceuticals Corporation United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
June 29, 2009
Wyeth, Portfolio of Products
Merger/Acquisition
January 25, 2009
--


Stock Quotes

Company Lookup
Recently Viewed
AKS $18.69 USD +0.36

Market data is delayed at least 20 minutes.

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States
Mccombs School Of Business At The University Of Texas At Austin United States

Companies Toolbox

Company Tools
Investing Tools

SEARCH FOR JOBS

Post a Job
See all Job Listings

Jobs by SimplyHired



Close Recommend A Data Enhancement Or Correction

For Wyeth Private

Submitting this data update / error report instantly puts the correct information in the hands of our researcher, who will investigate your report and, if necessary, make the changes to the company profile. Be sure to fill out the form completely.

Required Information Missing - Please enter your information in the following field(s):
DATA TO BE REVIEWED
Page Section*

Please indicate in which section the error appears. Section headers are in light gray type at the top of each CIC page module.

Data Point*

Please indicate which data is in error.

CONTACT INFORMATION

Please provide your name and email address in case our researchers need to get in touch with you as they investigate the error.

Your Name*
Your E-Mail Address*
YOUR RECOMMENDATION

Describe why you feel the data point is incorrect and indicate sources our researchers should check when they investigate the error.

Cancel Submit
You can drag this form within your browser window.

Thank you for submitting your information. We investigate data update requests and error reports as quickly as possible. Since some are easier to investigate than others, please be patient as we perform our research; it could take several weeks, depending on the nature of the error and whether your company is public or private.

You can drag this form within your browser window.